Monoclonal Antibodies In Veterinary Health Global Market Report 2025

Global Monoclonal Antibodies In Veterinary Health Market Report 2025

Monoclonal Antibodies In Veterinary Health Global Market Report 2025 – By Animal Type (Dogs, Other Animal Types), By Application (Dermatology, Pain, Other Applications), By End-User (Veterinary Hospitals, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Monoclonal Antibodies In Veterinary Health Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Monoclonal Antibodies In Veterinary Health Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Monoclonal Antibodies In Veterinary Health Global Market Report 2025

Proud Members Of

Monoclonal Antibodies In Veterinary Health Market Definition

Monoclonal antibodies in veterinary health are specialized proteins engineered to target and neutralize specific pathogens or toxins in animals, aiding in the diagnosis and treatment of various diseases. They are created by cloning a single type of immune cell to produce identical antibodies that precisely bind to their target.

The main types of animals in monoclonal antibodies in veterinary health are dogs and others. A dog refers to a domesticated mammal (Canis lupus familiaris) that is commonly kept as a pet or working animal. These antibodies find applications in Dermatology, pain management, and others, serving end users such as veterinary hospitals and others.

Monoclonal Antibodies In Veterinary Health Market Segmentation

The monoclonal antibodies in veterinary health market covered in this report is segmented –

1) By Animal Type: Dogs, Other Animal Types

2) By Application: Dermatology, Pain, Other Applications

3) By End-User: Veterinary Hospitals, Other End-Users

Subsegments:

1) By Dogs: Canine Infectious Diseases, Canine Cancer Treatment, Canine Autoimmune Disorders, Canine Allergies

2) By Other Animal Types: Cats, Horses, Cattle, Swine, poultry, Aquatic Animals, Small Mammals

Monoclonal Antibodies In Veterinary Health Market Size and growth rate 2025 to 2029: Graph

Monoclonal Antibodies In Veterinary Health Market Size 2025 And Growth Rate

The monoclonal antibodies in veterinary health market size has grown rapidly in recent years. It will grow from $0.8 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to an increase in pet ownership worldwide, the prevalence of chronic diseases in animals, an increase in the number of pet adoption rates, and increased health concerns among pet owners.

Monoclonal Antibodies In Veterinary Health Market Growth Forecast

The monoclonal antibodies in veterinary health market size is expected to see rapid growth in the next few years. It will grow to $1.61 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the increasing pet population, rising pet expenditure, growing prevalence of canine atopic dermatitis, increasing demand for advanced veterinary healthcare, and rising importance of animal health. Major trends in the forecast period include advancements in biotechnology and research, genetic engineering advancements, innovative treatments, advancements in antibody-based therapeutics, and technological advancements in antibody engineering.

Book your 30 minutes free consultation with our research experts

Monoclonal Antibodies In Veterinary Health Market Driver: Rising Animal Disease Incidences Drive Growth Of Monoclonal Antibodies In Veterinary Health Market

The rising animal disease incidences are expected to propel the growth of the monoclonal antibodies in veterinary health market going forward. The rising incidence of animal diseases is driven by intensified farming practices, which increase the risk of infectious disease spread, and climate change, which expands the range of disease vectors such as ticks and mosquitoes. Monoclonal antibodies are highly useful for treating animal diseases as they target specific pathogens or proteins involved in disease processes, offering precise and effective treatments. For instance, in June 2024, according to a report published by the GOV.UK, a UK-based government website, between April 2023 and March 2024, the number of animals slaughtered due to TB incidents rose by 5% in England to 21,298, and by 17% in Wales to 11,197. The rising animal disease incidences are driving the growth of monoclonal antibodies in veterinary health market.

Global Monoclonal Antibodies In Veterinary Health Market Major Players

Major companies operating in the monoclonal antibodies in veterinary health market are Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Bio-Rad Laboratories Inc., Eli Lilly and Company, GenScript Biotech Corporation, Abcam plc, Heska Corporation, Neogen Corporation, iNova Pharmaceuticals, Ceva Santé Animale S.A., Biogénesis Bagó S.A., TransGen Biotech Co. Ltd., AbCellera Biologics Inc., Areteia Therapeutics Inc., Esco Aster Pte Ltd, PetMedix Ltd., Vaxine Pty Ltd

Global Monoclonal Antibodies In Veterinary Health Market Trend: New Monoclonal Antibody Treatments For Osteoarthritis In Pets

Major companies operating in the monoclonal antibodies in veterinary health market are focusing on developing innovative veterinary therapeutic solutions, such as anti-NGF monoclonal antibody treatment to address conditions such as chronic pain and inflammation in animals. Anti-NGF monoclonal antibody treatment refers to a therapeutic approach that targets and inhibits nerve growth factor (NGF) to reduce pain and inflammation in animals suffering from chronic pain conditions. For instance, in May 2023, Zoetis, a US-based animal health company, received FDA approvals for Librela (bedinvetmab injection), the first monoclonal antibody treatment for controlling pain associated with osteoarthritis (OA) in dogs, which is administered as a once-monthly injection, and Apoquel Chewable, the first chewable medication specifically for managing allergic itch and inflammation in dogs aged one year or older. Librela is a monoclonal antibody that targets and inhibits nerve growth factor (NGF). By blocking NGF, Librela helps to prevent these pain signals from reaching the brain, thereby reducing the sensation of pain in dogs with osteoarthritis. Librela represents a significant advancement in veterinary pain management, providing a novel approach to treating chronic pain in dogs.

Monoclonal Antibodies In Veterinary Health Market Merger And Acquisition: Ceva Santé Animale Acquires Scout Bio To Advance Biotechnology In Animal Health

In January 2024, Ceva Santé Animale, a France-based provider of animal health products and services, acquired Scout Bio Inc. for an undisclosed amount. With this acquisition, Ceva Santé aims to significantly enhance its global biotechnology efforts in animal health by leveraging Scout Bio's expertise in advanced therapies such as gene therapy and monoclonal antibodies, accelerating innovation to address chronic diseases in pets. Scout Bio Inc. is a US-based biotechnology company revolutionizing and developing a pipeline of monoclonal antibody therapies for chronic conditions in pets.

Regional Outlook For The Global Monoclonal Antibodies In Veterinary Health Market

North America was the largest region in the monoclonal antibodies in veterinary health market in 2024. The regions covered in the monoclonal antibodies in veterinary health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the monoclonal antibodies in veterinary health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Monoclonal Antibodies In Veterinary Health Market?

The monoclonal antibodies in veterinary health market consist of sales of diagnostic kits, therapeutic drugs, research reagents, monoclonal antibody drugs, and therapeutic formulations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Monoclonal Antibodies In Veterinary Health Industry?

The monoclonal antibodies in veterinary health market research report is one of a series of new reports from The Business Research Company that provides monoclonal antibodies in veterinary health market statistics, including monoclonal antibodies in veterinary health industry global market size, regional shares, competitors with a monoclonal antibodies in veterinary health market share, detailed monoclonal antibodies in veterinary health market segments, market trends and opportunities, and any further data you may need to thrive in the monoclonal antibodies in veterinary health industry. This monoclonal antibodies in veterinary health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Monoclonal Antibodies In Veterinary Health Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	0.92 billion
Revenue Forecast In 2034	$1.61 billion
Growth Rate	CAGR of 15.0% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The monoclonal antibodies in veterinary health market covered in this report is segmented – 1) By Animal Type: Dogs, Other Animal Types 2) By Application: Dermatology, Pain, Other Applications 3) By End-User: Veterinary Hospitals, Other End-Users Subsegments: 1) By Dogs: Canine Infectious Diseases, Canine Cancer Treatment, Canine Autoimmune Disorders, Canine Allergies 2) By Other Animal Types: Cats, Horses, Cattle, Swine, Poultry, Aquatic Animals, Small Mammals
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Bio-Rad Laboratories Inc., Eli Lilly and Company, GenScript Biotech Corporation, Abcam plc, Heska Corporation, Neogen Corporation, iNova Pharmaceuticals, Ceva Santé Animale S.A., Biogénesis Bagó S.A., TransGen Biotech Co. Ltd., AbCellera Biologics Inc., Areteia Therapeutics Inc., Esco Aster Pte Ltd, PetMedix Ltd., Vaxine Pty Ltd
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Monoclonal Antibodies In Veterinary Health Market Characteristics

3. Monoclonal Antibodies In Veterinary Health Market Trends And Strategies

4. Monoclonal Antibodies In Veterinary Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Monoclonal Antibodies In Veterinary Health Growth Analysis And Strategic Analysis Framework

5.1. Global Monoclonal Antibodies In Veterinary Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Monoclonal Antibodies In Veterinary Health Market Growth Rate Analysis

5.4. Global Monoclonal Antibodies In Veterinary Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Monoclonal Antibodies In Veterinary Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Monoclonal Antibodies In Veterinary Health Total Addressable Market (TAM)

6. Monoclonal Antibodies In Veterinary Health Market Segmentation

6.1. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dogs

Other Animal Types

6.2. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dermatology

Pain

Other Applications

6.3. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Veterinary Hospitals

Other End-Users

6.4. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Canine Infectious Diseases

Canine Cancer Treatment

Canine Autoimmune Disorders

Canine Allergies

6.5. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Animal Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cats

Horses

Cattle

Swine

Poultry

Aquatic Animals

Small Mammals

7. Monoclonal Antibodies In Veterinary Health Market Regional And Country Analysis

7.1. Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market

8.1. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Monoclonal Antibodies In Veterinary Health Market

9.1. China Monoclonal Antibodies In Veterinary Health Market Overview

9.2. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Monoclonal Antibodies In Veterinary Health Market

10.1. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Monoclonal Antibodies In Veterinary Health Market

11.1. Japan Monoclonal Antibodies In Veterinary Health Market Overview

11.2. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Monoclonal Antibodies In Veterinary Health Market

12.1. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Monoclonal Antibodies In Veterinary Health Market

13.1. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Monoclonal Antibodies In Veterinary Health Market

14.1. South Korea Monoclonal Antibodies In Veterinary Health Market Overview

14.2. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Monoclonal Antibodies In Veterinary Health Market

15.1. Western Europe Monoclonal Antibodies In Veterinary Health Market Overview

15.2. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Monoclonal Antibodies In Veterinary Health Market

16.1. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Monoclonal Antibodies In Veterinary Health Market

17.1. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Monoclonal Antibodies In Veterinary Health Market

18.1. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Monoclonal Antibodies In Veterinary Health Market

19.1. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Monoclonal Antibodies In Veterinary Health Market

20.1. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Monoclonal Antibodies In Veterinary Health Market

21.1. Eastern Europe Monoclonal Antibodies In Veterinary Health Market Overview

21.2. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Monoclonal Antibodies In Veterinary Health Market

22.1. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Monoclonal Antibodies In Veterinary Health Market

23.1. North America Monoclonal Antibodies In Veterinary Health Market Overview

23.2. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Monoclonal Antibodies In Veterinary Health Market

24.1. USA Monoclonal Antibodies In Veterinary Health Market Overview

24.2. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Monoclonal Antibodies In Veterinary Health Market

25.1. Canada Monoclonal Antibodies In Veterinary Health Market Overview

25.2. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Monoclonal Antibodies In Veterinary Health Market

26.1. South America Monoclonal Antibodies In Veterinary Health Market Overview

26.2. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Monoclonal Antibodies In Veterinary Health Market

27.1. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Monoclonal Antibodies In Veterinary Health Market

28.1. Middle East Monoclonal Antibodies In Veterinary Health Market Overview

28.2. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Monoclonal Antibodies In Veterinary Health Market

29.1. Africa Monoclonal Antibodies In Veterinary Health Market Overview

29.2. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape And Company Profiles

30.1. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape

30.2. Monoclonal Antibodies In Veterinary Health Market Company Profiles

30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GlaxoSmithKline plc (GSK) Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Monoclonal Antibodies In Veterinary Health Market Other Major And Innovative Companies

31.1. Regeneron Pharmaceuticals Inc.

31.2. Zoetis Inc.

31.3. MSD Animal Health

31.4. Elanco Animal Health Incorporated

31.5. Bio-Rad Laboratories Inc.

31.6. Eli Lilly and Company

31.7. GenScript Biotech Corporation

31.8. Abcam plc

31.9. Heska Corporation

31.10. Neogen Corporation

31.11. iNova Pharmaceuticals

31.12. Ceva Santé Animale S.A.

31.13. Biogénesis Bagó S.A.

31.14. TransGen Biotech Co. Ltd.

31.15. AbCellera Biologics Inc.

32. Global Monoclonal Antibodies In Veterinary Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Monoclonal Antibodies In Veterinary Health Market

34. Recent Developments In The Monoclonal Antibodies In Veterinary Health Market

35. Monoclonal Antibodies In Veterinary Health Market High Potential Countries, Segments and Strategies

35.1 Monoclonal Antibodies In Veterinary Health Market In 2029 - Countries Offering Most New Opportunities

35.2 Monoclonal Antibodies In Veterinary Health Market In 2029 - Segments Offering Most New Opportunities

35.3 Monoclonal Antibodies In Veterinary Health Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Animal Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Sanofi S.A. Financial Performance

Table 77: Bristol-Myers Squibb Company Financial Performance

Table 78: GlaxoSmithKline plc (GSK) Financial Performance

Table 79: Amgen Inc. Financial Performance

Table 80: Boehringer Ingelheim International GmbH Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Animal Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Sanofi S.A. Financial Performance

Figure 77: Bristol-Myers Squibb Company Financial Performance

Figure 78: GlaxoSmithKline plc (GSK) Financial Performance

Figure 79: Amgen Inc. Financial Performance

Figure 80: Boehringer Ingelheim International GmbH Financial Performance

The Business Research Company offers the companion animal veterinary vaccines market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the veterinary vaccines market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the veterinary pharmaceuticals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the veterinary parasiticides market research report 2022 with industry size, share, segments and market growth

Global Cattle Feed And Feed Additives Market 2022 – Market Opportunities And Strategies

Global Animal Antibiotics and Antimicrobials Market Outlook, Opportunities And Strategies – Includes Animal Antibiotics and Antimicrobials Market Size

What Is The Veterinary Services Market Overview In 2022?

Global Animal Based Protein Supplements Market 2022 – Market Opportunities And Strategies

Insurance Analytics Global Market Report 2025 – By Component (Solution, Service), By Deployment Model (On premises, Cloud), By Enterprise Size (Large Enterprises, Small And Medium Enterprises (SMEs)), By Application (Claims Management, Risk Management, Customer Management And Personalization, Process Optimization, Other Applications), By End User (Insurance Companies, Government Agencies, Third Party Administrators, Brokers And Consultancies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Mobile And Wireless Backhaul Global Market Report 2025 – By Component (Equipment, Services), By Network Technology (3G And 2G, 4G, 5G), By Application (Financial Services, Medical, Retail, Media, Government, Communication, Public Utilities, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Neuroscience Antibodies & Assays Global Market Report 2025 – By Product (Consumables, Instruments ), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies ), By Application (In Vitro Diagnostics, Research, Drug Discovery ), By End User (Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Space Situational Awareness Global Market Report 2025 – By Solution (Service, Payload Systems, Software), By Capability (Detect, Track, And Identify (D/T/Id), Threat Warning And Assessment, Characterization), By Object (Mission-Related Debris, Rocket Bodies, Fragmentation Debris, Functional Spacecraft, Non-Functional Spacecraft, Other Objects), By Orbital Range (Near-Earth, Deep Space), By End Use (Commercial, Government And Military) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nut Ingredients Global Market Report 2025 – By Type( Cashews, Walnuts, Almonds, Hazelnuts ), By Form( Roasted, Chopped, Raw, Powdered ), By Application( Snacks And Bars, Confectionary, Baked Products, Dairy Products, Beverages, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Monoclonal Antibodies In Veterinary Health market?

How will the Monoclonal Antibodies In Veterinary Health market drivers and restraints affect the market dynamics? What forces will shape the Monoclonal Antibodies In Veterinary Health industry going forward?

The Monoclonal Antibodies In Veterinary Health market major growth driver - Rising Animal Disease Incidences Drive Growth Of Monoclonal Antibodies In Veterinary Health Market. For further insights on the Monoclonal Antibodies In Veterinary Health market, request a sample here

What is the forecast market size or the forecast market value of the Monoclonal Antibodies In Veterinary Health market?

The Monoclonal Antibodies In Veterinary Health market size has grown strongly in recent years. The monoclonal antibodies in veterinary health market size has grown rapidly in recent years. It will grow from $0.8 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to an increase in pet ownership worldwide, the prevalence of chronic diseases in animals, an increase in the number of pet adoption rates, and increased health concerns among pet owners. The monoclonal antibodies in veterinary health market size is expected to see rapid growth in the next few years. It will grow to $1.61 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the increasing pet population, rising pet expenditure, growing prevalence of canine atopic dermatitis, increasing demand for advanced veterinary healthcare, and rising importance of animal health. Major trends in the forecast period include advancements in biotechnology and research, genetic engineering advancements, innovative treatments, advancements in antibody-based therapeutics, and technological advancements in antibody engineering. For further insights on the Monoclonal Antibodies In Veterinary Health market, request a sample here

How is the Monoclonal Antibodies In Veterinary Health market segmented?

The monoclonal antibodies in veterinary health market covered in this report is segmented –
1) By Animal Type: Dogs, Other Animal Types
2) By Application: Dermatology, Pain, Other Applications
3) By End-User: Veterinary Hospitals, Other End-Users Subsegments:
1) By Dogs: Canine Infectious Diseases, Canine Cancer Treatment, Canine Autoimmune Disorders, Canine Allergies
2) By Other Animal Types: Cats, Horses, Cattle, Swine, Poultry, Aquatic Animals, Small Mammals For further insights on the Monoclonal Antibodies In Veterinary Health market, request a sample here

Which region has the largest share of the Monoclonal Antibodies In Veterinary Health market? What are the other regions covered in the report?

Who are the major players in the Monoclonal Antibodies In Veterinary Health market?

What are the key trends in the Monoclonal Antibodies In Veterinary Health market?

Major trends in the Monoclonal Antibodies In Veterinary Health market include New Monoclonal Antibody Treatments For Osteoarthritis In Pets. For further insights on the Monoclonal Antibodies In Veterinary Health market, request a sample here.

What are the major opportunities in the Monoclonal Antibodies In Veterinary Health market? What are the strategies for the Monoclonal Antibodies In Veterinary Health market?

For detailed insights on the major opportunities and strategies in the Monoclonal Antibodies In Veterinary Health market, request a sample here.

How does the Monoclonal Antibodies In Veterinary Health market relate to the overall economy and other similar markets?

For detailed insights on Monoclonal Antibodies In Veterinary Health's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Monoclonal Antibodies In Veterinary Health industry?

For detailed insights on the mergers and acquisitions in the Monoclonal Antibodies In Veterinary Health industry, request a sample here.

What are the key dynamics influencing the Monoclonal Antibodies In Veterinary Health market growth? SWOT analysis of the Monoclonal Antibodies In Veterinary Health market.

For detailed insights on the key dynamics influencing the Monoclonal Antibodies In Veterinary Health market growth and SWOT analysis of the Monoclonal Antibodies In Veterinary Health industry, request a sample here.